How Beta-Blockers, Diuretics, and Clonidine Decrease Libido and Sexual Function in Males

1. Beta-Blockers (Beta-Adrenoceptor Antagonists)

Peripheral Mechanism - Smooth Muscle in the Penis

• Only about 10% of adrenoceptors in penile tissue are beta-type, and their stimulation normally mediates smooth muscle relaxation (the pro-erectile direction).
• Nonselective beta-blockers (e.g., propranolol, carvedilol) block these penile beta-receptors, attenuating smooth muscle relaxation - this effect is mediated via a prejunctional beta-2 receptor mechanism.
• The net result is reduced corporal smooth muscle relaxation and impaired erection.
• Selective beta-1 antagonists (e.g., metoprolol, atenolol) spare the beta-2 receptors and show much lower rates of erectile dysfunction.

Central Mechanism - Hormonal Depression

• Beta-antagonists also exert an inhibitory effect within the CNS, possibly leading to decreased sex hormone levels (including testosterone), which directly reduces libido.
• CNS beta-receptor blockade may reduce central dopaminergic drive, which is a key pathway for sexual desire.

Clinical Note

• Nonselective beta-blockers like propranolol carry significantly higher ED rates than placebo or ACE inhibitors.
• Carvedilol (which also blocks alpha-1) is associated with worsening sexual function despite its vasodilatory component.
• Nebivolol, a beta-1-selective blocker that also releases NO (nitric oxide), does not decrease sexual activity and may even have positive effects on erectile function.

2. Diuretics

Thiazide Diuretics (e.g., hydrochlorothiazide, chlorthalidone)

• Clinical evidence is robust: the large UK Medical Research Council trial showed twice as many men taking thiazides reported erectile dysfunction compared with propranolol or placebo.
• The TOMHS study confirmed the prevalence of ED at 2 years on low-dose thiazide was twice that of placebo.
• The mechanism of thiazide-induced ED remains incompletely understood. Proposed hypotheses include:
  • Reduction in blood flow to the penile vasculature (by reducing circulating volume and cardiac output)
  • Possible effects on smooth muscle function
  • Zinc depletion (thiazides increase urinary zinc excretion; zinc is needed for testosterone synthesis)

Spironolactone (Potassium-Sparing / Aldosterone Antagonist)

• Unlike thiazides, spironolactone has a well-characterized hormonal mechanism:
  • It is a nonselective mineralocorticoid receptor antagonist with moderate affinity for progesterone and androgen receptors
  • It directly blocks androgen receptors, effectively reducing androgenic activity
  • This leads to decreased libido (via reduced androgen signaling in the CNS) and may cause gynecomastia
• Eplerenone, a more selective mineralocorticoid antagonist, has fewer sexual side effects because it lacks the progesterone/androgen receptor affinity.

3. Clonidine (Central Alpha-2 Agonist)

Central Mechanism

• Clonidine binds to alpha-2 adrenoceptors in the CNS (specifically in the medulla/locus coeruleus) and inhibits sympathetic outflow
• This blunts the central sympathetic activation that normally supports sexual arousal, desire, and the initiation of erection
• It also alters the balance between sympathetic and parasympathetic tone centrally

Peripheral Mechanism

• Alpha-2 receptor agonism reduces norepinephrine release from presynaptic postganglionic sympathetic neurons
• Alpha-2 agonists (including clonidine) are associated with decreased erectile function, thought to relate to both peripheral and central mechanisms
• This is in contrast to alpha-2 antagonists, which would promote norepinephrine release and potentially facilitate erection

Additional Effects

• Clonidine may cause galactorrhea (via dopamine suppression), and elevated prolactin from this mechanism can further suppress testosterone and libido

Summary Table

Key Clinical Takeaway

• Campbell-Walsh-Wein Urology, Table 68.10 (antihypertensives and sexual function overview)
• Smith & Tanagho's General Urology, 19th Ed., p. 124-143 (medication-induced ED mechanisms)